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Abstract
Despite clear evidence that polymeric nitric oxide (NO) release coatings reduce the foreign body
response (FBR) and may thus improve the analytical performance of in vivo continuous glucose
monitoring devices when used as sensor membranes, the compatibility of the NO release
chemistry with that required for enzymatic glucose sensing remains unclear. Herein, we describe
the fabrication and characterization of NO-releasing polyurethane sensor membranes using NO
donor-modified silica vehicles embedded within the polymer. In addition to demonstrating tunable
NO release as a function of the NO donor silica scaffold and polymer compositions and
concentrations, we describe the impact of the NO release vehicle and its release kinetics on
glucose sensor performance.
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1. Introduction
Strict monitoring and control of blood glucose levels are essential for effective diabetes
management (Wang, 2008). Since conventional glucose monitoring (e.g., the finger prick
method) provides only discrete snapshots of blood glucose levels, analytical methods that
enable continuous monitoring of glucose concentration fluctuations via implantable enzyme-
based electrochemical sensors have been sought to improve diabetes management (Heller
and Feldman, 2008; Klonoff, 2005b; Ward et al., 2002). Despite US Food and Drug
Administration approval for certain devices, most sensors have serious shortcomings
including poor accuracy, unpredictable signal stability, lag time in sensor response, frequent
calibration requirement, and short lifetimes that limit their clinical utility (Klonoff, 2005a,b).
Undesirable sensor performance has been attributed to the foreign body response (FBR) and
biofouling (Wisniewski et al., 2000; Wisniewski and Reichert, 2000). As the outer surface of
the sensor influences the FBR directly, recent work has focused on the development of more
biocompatible sensor membranes to mitigate the FBR (Wilson and Gifford, 2005; Wilson
and Hu, 2000). The general consensus is that new strategies to improve long-term in vivo
sensor performance should: (1) reduce the initial inflammatory response; (2) enhance wound
healing; and, (3) avoid biosensor degradation (Gifford et al., 2005).
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Due to nitric oxide's (NO) role as an endogenous antibacterial agent (Williams, 2003), we
reported on the synthesis of sol–gel-derived coatings (e.g., xerogels) capable of storing and
spontaneously releasing NO (Hetrick and Schoenfisch, 2006; Nablo et al., 2005b; Riccio et
al., 2009). These materials were shown to reduce bacterial adhesion (Nablo et al., 2001;
Nablo and Schoenfisch, 2003), kill bacteria that did manage to adhere (Hetrick and
Schoenfisch, 2007; Hetrick et al., 2008; Privett et al., 2010), and reduce in vivo infection
rates (Nablo et al., 2005a). Furthermore, the NO release was shown to reduce collagen
capsule thickness around a subcutaneous implant by >50% relative to controls in a rat model
(Hetrick et al., 2007). Concomitantly, the NO-releasing implant lessened the chronic
inflammatory response at the tissue/implant interface by >30% and enhanced blood vessel
formation by >77% versus controls (Hetrick et al., 2007). Nitric oxide-releasing sensors
have exhibited improved biocompatibility and sensor performance (Gifford et al., 2005; Yan
et al., 2011). For example, Gifford et al. reported reduced inflammatory response for
subcutaneously implanted NO-releasing glucose sensors over 3 d (Gifford et al., 2005). In
blood, Yan et al. described improved hemocompatibilty and in vivo sensor performance for
an intravenous NO-releasing glucose/lactate sensor (Yan et al., 2011). We recently reported
enhanced in vivo glucose recovery from NO-releasing microdialysis probes during long-
term (i.e., 2 weeks) implantation (Nichols et al., 2011). Collectively, these studies indicate
that NO release is a highly promising strategy that may solve the lingering biocompatibility
problems encountered when glucose biosensors are implanted in vivo.
Based on the reduced FBR as a function of NO release, we sought to combine the
chemistries of NO release with enzymatic glucose sensing to fabricate continuous glucose
monitoring devices with improved biocompatibility and extended analytical performance.
Although promising with respect to reduced capsule formation and implant-associated
infection, the xerogel films resulted in unusually low glucose response when used to
fabricate glucose biosensors (Shin et al., 2004). The glucose impermeability of the xerogel
film was attributed to enhanced hydrolysis and condensation rates catalyzed by the
aminosilanes and exposure to high pressures of NO (necessary to form the
diazeniumdiolate-based NO donors). To address the inadequate glucose permeability, we
fabricated functional NO-releasing glucose biosensors by patterning xerogel microarrays on
top of (Oh et al., 2005) or physically entrapping ground xerogel particles within (Shin et al.,
2004) standard polyurethane sensor membranes. These polymer configurations allowed for
enhanced glucose sensitivity relative to sensors completely coated with xerogel films
because significant potions of the underlying electrode surface remained unmodified by the
xerogel.
To date, a key challenge for the development of NO-releasing glucose biosensors has been
limited NO release. While our previously published hybrid NO-releasing xerogel particle/
polyurethane biosensor exhibited excellent analytical response characteristics (e.g.,
sensitivity, linear response, and lifetime), the NO flux and release duration were limited to a
maximum of ∼90 pmol cm−2 s−1 for 2 d (Shin et al., 2004). The sensors described more
recently by Gifford et al. and Yan et al. released NO with average maximum fluxes of 7.52
pmol cm−2 s−1 and 40 pmol cm−2 s−1 for 18 h and 7 d, respectively (Gifford et al., 2005;
Yan et al., 2011). As such, a void exists regarding the optimal level and duration of NO
release required to mitigate the FBR and influence sensor performance. Herein, we report
the synthesis of NO-releasing glucose sensor membranes with a wide range of NO fluxes (5
pmol cm−2 s−1 to 2.5 nmol cm−2 s−1) and release durations (16 h to 14 d) using NO donor-
modified silica nanoparticles. The NO-releasing polymers are then used to fabricate
functional glucose biosensors to further evaluate sensor response and stability as a function
of NO release.
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2. Materials and methods
2.1. Reagents and materials
Glucose oxidase (type VII from Aspergillus niger), hydrogen peroxide (30% v/v), L-proline,
and β-D-glucose anhydrous were purchased from Sigma (St. Louis, MO). Ethanol (EtOH),
tetrahydrofuran (THF), and aqueous ammonium hydroxide solution (14.8 M) were
purchased from Fisher Scientific (Pittsburgh, PA). Methyltrimethoxysilane (MTMOS) was
purchased from Fluka (Buchs, Switzerland). N-(6-aminohexyl)aminopropyltrimethoxysilane
(AHAP3), N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAP3), 3-
methylaminopropyltrimethoxysilane (MAP3), 3-mercaptopropyltrimethoxysilane
(MPTMS), tetramethoxysilane (TMOS), and tetraethoxysilane (TEOS) were purchased from
Gelest (Tullytown, PA). Tecoplast TP-470-000, Tecophilic HP-93A-100, and Tecoflex
SG-80A (TPU) were gifts from Thermedics (Woburn, MA). Hydrothane AL 25-80A (HPU)
was a gift from AdvanSource Biomaterials Corporation (Wilmington, MA). A Griess
reagent kit was purchased from Promega (Madison, WI). Water was purified (18.2 MΩ/cm;
total organic contents <6 ppb) with a Milli-Q UV Gradient A10 system (Millipore Corp.,
Bedford, MA). Nitric oxide, nitric oxide calibration gas (26.4 ppm; balance N2), nitrogen
and argon (Ar) gases were purchased from National Welders Supply (Durham, NC). All
other reagents and solvents were analytical-reagent grade and used as received.
2.2. Preparation of NO-releasing dopant
1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (PROLI/NO) was prepared by
converting L-proline to NO donor form following a procedure reported by Saavedra et al.
(1996). Nitric oxide-releasing silica particles were synthesized based on the sol–gel process
via the co-condensation of an aminosilane (i.e., MAP3, AEAP3, or AHAP3) or
mercaptosilane (i.e., MPTMS) in a range of concentrations (65–75 mol%) with
tetraethyoxysilane (TEOS) or tetramethoxysilane (TMOS) in similarly to those reported in
previous studies (Riccio et al., 2011; Shin et al., 2007; Shin and Schoenfisch, 2008).
Subsequent diazeniumdiolation of the amine-containing particles was performed under high
pressure of NO for 3 d in the presence of sodium methoxide at room temperature.
Nitrosation of the thiol-containing nanoparticles was carried out by reaction with acidified
nitrite in the dark at 0 °C. The details of the NO-releasing characteristics and particle sizes
for each particle system are provided in supporting information (Table S1).
2.3. Hybrid sol–gel/polyurethane glucose sensor fabrication
A platinum macroelectrode (0.3 cm radius and 0.031 cm2 platinum surface area) was used to
fabricate hybrid sol–gel/polyurethane glucose biosensors that consisted of two distinct
layers: glucose oxidase and NO-releasing polyurethane. Fabrication of the glucose sensor
was adapted from a procedure described by Shin et al. (Shin et al., 2004). Briefly, glucose
oxidase (GOx) was immobilized within a sol–gel matrix on a polished platinum electrode by
casting 3 μL of a GOx sol. The enzyme-containing sol was prepared by dissolving 9 mg of
GOx into 75 μL of water and adding 50 μL of this solution into 25 μL MTMOS and 100 μL
EtOH followed by mixing for 10 min. The NO-releasing layer was prepared by dispersing
silica particles in a polyurethane (PU) polymer solution consisting of 20 mg mL−1 50% w/w
TPU and HPU dissolved in 50% v/v THF/EtOH solution. The NO-releasing layer was
formed by casting 5 μL of the resulting 9–144 mg mL−1 NO-releasing particles in a PU
polymer solution (0.2–2.4 mg cm−2). Particle concentration rather than casting volume was
increased when increasing particle concentration per surface area. For instances where an
additional polyurethane layer was cast on top of the NO-releasing layer, 20 μL of 20–60 mg
mL−1 polyurethane polymer solution dissolved in THF was used and each layer was dried
under ambient conditions for 30 min before casting the subsequent layer.
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2.4. Film fabrication and methods of film study
Glass substrates were prepared via sonication in EtOH and subsequent UV-ozone cleaning
for 20 min in a BioForce Tip Cleaner (Ames, IA). The NO-releasing particle-dispersed
polyurethane solution described previously was spread-cast (36.2 μL) onto a glass substrate
(2.08 cm2). For films with an additional PU layer on the NO-releasing layer, PU polymer
solution was cast (141 μL) in the same manner as the electrode casting procedure. Each
layer was dried under ambient conditions for 30 min and stored in the dark at −20 °C under
vacuum until used. This storage method was adopted to assure NO donor stability. Although
the N-diazeniumdiolated particle-doped films could be stored at ambient condition
(humidity 40% at room temperature) without loss of NO for 2 d, NO storage was sacrificed
(∼10%) under more humid conditions (i.e., 90% humidity, 23.7–25.0 °C). Nitric oxide
release from NO-releasing silica particle-doped polyurethane was characterized using a
Sievers model 280i chemiluminesence NO analyzer (Boulder, CO). Films were immersed in
0.01 M PBS (pH 7.4) buffer solution at 37 °C sparged with 80 mL min−1 nitrogen with
additional nitrogen supported to the flask to match the instrument collection rate of 200 mL
min−1. The instrument was calibrated using 26.4 ppm NO gas (balance N2) and air passed
through a Sievers NO zero filter. When measuring NO from nitrosothiol-based materials, the
sample flask was shielded from light to prevent light-initiated NO release. Total NO release
was determined spectrophotometrically by measuring the conversion of NO to nitrite
(NO2−) using the Griess assay (Chae et al., 2004). After soaking NO-releasing films in PBS
buffer solution at 37 °C for a period exceeding their NO release, 50 μL of the solution was
mixed with 100 μL of Griess reagent (1% w/v sulfanilamide in 5% v/v phosphoric acid and
0.1% w/v N-(1-naphthyl)ethylenediamine dihydrochloride) and incubated at room
temperature for 10 min. Absorbance of these solutions was measured at 540 nm using a
Labsystem MultiskanRC microplate spectrophotometer (Helsinki, Finland). Total nitrite
concentration was determined using a calibration curve constructed with a standard nitrite
solution. The water uptake of polyurethane films was determined by measuring the mass of
glass substrates cast with 141 μL of 40 mg mL−1 polyurethane before/after soaking in PBS
for 3 h. The degree of silica particle leaching from the sensor membranes was assessed via
dynamic light scattering (DLS). The NO-releasing polyurethane-coated glass substrates
were immersed in 2 mL PBS and incubated at 37 °C for 7 d. The concentration of silica
particles that leached into the soak solution was determined by measuring the derived count
rate that varied linearly with particle concentration (Amstad et al., 2009; Lahtinen et al.,
2010). The derived count rate was then fit to a calibration curve of known particle
concentrations. Film thickness was measured with a Tencor Alpha-Step 200 Profilometer
(San Jose, CA). Half of the NO-releasing silica particle-doped polyurethane coating was
removed from the glass substrate and the resulting interface was probed to determine film
thickness.
2.5. Sensor performance of hybrid sol–gel/polyurethane glucose sensor
The analytical performance (i.e., sensitivity, dynamic range, and response time (t95%)) of the
biosensors was evaluated via chronoamperometry using a CH Instruments 1030A
potentiostat (Austin, TX). All electrochemical measurements were performed in 0.01 M
PBS (pH 7.4) at room temperature using a three-electrode configuration with a Ag/AgCl
(3.0 M KCl) reference electrode, a platinum wire counter electrode, and a glucose biosensor
as the working electrode. Glucose sensors were first hydrated in PBS for 1 h and polarized
for 20 min to stabilize glucose response. Indeed, sensor response effects due to NO release
and changes in membrane permeability (water uptake) were shown to significantly decrease
during this preconditioning period (data not shown). Response and calibration curves were
obtained by injecting 1 M glucose aliquots into 30 mL PBS at room temperature under
constant stirring and an applied potential of +0.6 V vs. Ag/AgCl (Schoenfisch et al., 2006;
Shin et al., 2004). Permeability ( ) was defined electrochemically as the ratio of peak
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current at the hybrid sol–gel/polyurethane glucose sensor (ΔIx) and bare platinum electrode
(ΔIb) response at either 0.79 mM H2O2 ( ) or air saturated solution ( ) (Schoenfisch
et al., 2006; Shin et al., 2008). Amperometric selectivity coefficients were calculated using
Eq. (1) (Shin et al., 2008) where ΔIGlu and ΔIj are the measured current values for glucose
(Glu) and interfering species (j = ascorbic acid, uric acid, and nitrite), respectively.
(1)
The concentration of each interfering substance (cj) was 100 μM. The glucose concentration
(cGlu) employed for selectivity coefficient determination was 5.6 mM.
3. Results and discussion
3.1. NO-releasing glucose sensor
Nitric oxide-releasing glucose sensor membranes were prepared using polyurethanes doped
with NO-releasing silica particles. These membranes were then used as the outermost
coating for enzyme-based glucose sensors. Since NO release has previously been reported to
increase the background current of amperometric glucose sensors because of the overlapping
oxidation potentials of H2O2 and NO (+0.7 and +0.9 V vs. Ag/AgCl on platinum electrode,
respectively) (Gifford et al., 2005), an applied electrode potential of +0.6 V vs. Ag/AgCl
was selected to monitor glucose concentration in the presence of NO release to avoid
masking the H2O2 oxidation response at large NO fluxes (Figure S1). This potential
provided the optimal combination of adequate glucose sensitivity and minimal current
interference from NO oxidation. Glucose sensitivity was maintained independent of NO
release from the membrane. For example, the normalized sensitivity of RSNO–MPTMS/
TEOS particle-doped (0.6 mg cm−2) polyurethane-coated glucose sensors over 3 d was not
altered even though the NO flux from the membrane was changing appreciably. Of note, a
preconditioning period of 18 h was required with the addition of a polyurethane barrier layer
to extend the linear response (Figure S2). This change may be attributed to decreased water
uptake rate by the thicker membrane, as previously observed for other polyurethane coated
glucose sensors (Bindra et al., 1991; Yan et al., 2011).
The fabricated NO-releasing particle-doped membranes were characterized as having
adequate selectivity over known interferents (Heller and Feldman, 2008; Wilson and
Gifford, 2005). For example, glucose sensors prepared using RSNO-MPTMS/TEOS
particle-doped (0.6 mg cm−2) polyurethane membranes exhibited amperometric selectivity
coefficients of 0.55 ± 0.18, 0.88 ± 0.14, and −0.17 ± 0.13 for ascorbic acid, uric acid, and
nitrite over glucose, respectively.
3.2. Variation of type of NO donors
The NO-donor systems embedded in the 50% w/w TPU/HPU polyurethane membranes
enabled the comparison of NO release kinetics and payloads on sensor response. Two NO
donor classes were investigated: N-diazeniumdiolates and S-nitrosothiols. Briefly, N-
diazeniumdiolates are formed on secondary amines and produce NO upon decomposition by
protonation in aqueous solutions (Shin et al., 2007; Wang et al., 2002). Alternatively, S-
nitrosothiols (RSNO), endogenous transporters of NO, are formed on thiol precursors and
degraded by heat, light and/or copper ions to liberate NO (Al-Sa'doni and Ferro, 2004).
While NO donors may be synthesized as low molecular weight compounds or larger
macromolecules (e.g., dendrimers and silica particles) (Wang et al., 2002), the following
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NO-releasing scaffolds were chosen for study because of their low toxicity, stable nature,
and wide range of achievable NO-release: (1) PROLI/NO, a water soluble, N-
diazeniumdiolated low molecular weight compound derived from the amino acid proline; (2)
three types of N-diazeniumdiolate-modified silica particles (i.e., MAP3/TMOS, AEAP3/
TMOS, and AHAP3/TEOS); and (3) RSNO-modified silica particles (i.e., MPTMS/TEOS).
The NO release from N-diazeniumdiolate-modified silica particles was tuned via altering the
structure of the aminosilane precursors. For example, MAP3 does not contain a stabilizing
primary amine, and its decomposition rate in solution is greater than AHAP3 or AEAP3
(Shin et al., 2007; Shin and Schoenfisch, 2008). While both AEAP3 and AHAP3 contain a
secondary and a primary amine, the spacing between the two amines is increased from two
to six carbons resulting in altered N-diazeniumdiolate stability and ensuing NO release. The
RSNO-modified silica particle scaffold enables more sustained NO release compared to the
N-diazeniumdiolate-modified silica particles as the decomposition is based on different
mechanisms (thermal vs. proton) (Riccio et al., 2011).
Nitric oxide release from the particle-doped films was monitored in PBS (pH 7.4) at 37 °C
to mimic physiological conditions. Corresponding NO release data for each system studied
is provided in Table 1. Due to the short half-life of PROLI/NO (∼1.2 min), 99% of the
stored NO (∼3 μmol cm−2) was released within the first 10 min. The total amount of NO
delivered from PROLI/NO-doped polyurethane films was greater than any particle-doped
system of equivalent wt% of dopant. The AEAP3/TMOS particle-doped polyurethane
composition released a similar maximum NO flux (116.1 pmol cm−2 s−1) and total NO
amount (1.70 μmol cm−2) as previously reported materials shown to reduce capsule
formation and the chronic inflammatory response (Hetrick et al., 2007). However, the NO
release duration was limited (i.e., 20 h) and the NO flux was exhausted (i.e., undetectable)
after 24 h. Although MAP3/TMOS and AHAP3/TEOS particle-doped polyurethane
membranes were also characterized by limited NO release durations (i.e., ∼15 h), their
maximum NO fluxes were ∼4 times larger than the AEAP3/TMOS particle-doped films.
The MPTMS/TEOS particle-doped films exhibited significantly longer NO release durations
(∼2 weeks) representing significantly extended release compared to previously published
NO-releasing glucose sensors (Gifford et al., 2005; Shin et al., 2004). Of note, the maximum
NO flux was 4 times larger (i.e., 426.2 pmol cm−2 s−1) than the previous NO-releasing
materials shown to successfully mitigate the FBR (Hetrick et al., 2007). The NO fluxes and
delivery totals indicate that each type of NO-releasing sensor membrane, regardless of NO
donor type, may hold potential for improving the biocompatibility of implantable glucose
sensors. The multitude of NO-releasing membranes offers a wide range of tunability to
allow for diverse NO fluxes, durations, and amounts necessary for future studies aimed at
exploring the in vivo response of these sensors as a function of NO release.
The analytical performance of the NO-releasing sensors fabricated with the above
membranes was evaluated to assess the effects of the scaffold type and NO release on sensor
response. Similar to previously reported in vivo NO-releasing glucose sensors (Gifford et
al., 2005), the sensitivity and response time (t95%) of the fabricated sensors were found to be
applicable for in vivo glucose sensing (e.g., ∼150 nA mM−1 and <1 min, respectively).
Although the permeability of PROLI/NO-doped polyurethane films to H2O2 and O2 was not
significantly different from control membranes, glucose sensitivity was decreased by ∼51%.
We attribute this loss to the production of high local concentrations of NO affecting GOx
activity (Shin et al., 2004). When larger NO-releasing scaffolds (i.e., silica particles) were
used as dopants, glucose sensitivity decreased by ∼57% and ∼11% as compared to control
(i.e., non-particle-doped) and PROLI/NO-doped membrane, respectively. The permeability
of H2O2 through the particle-doped films also decreased by ∼58% compared to films
without particles or those doped with PROLI/NO. Perhaps related, the silica particle-doped
polyurethane films were significantly thicker than films without particles or with PROLI/NO
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(14 vs. 2 μm thick). While larger concentrations of NO may affect glucose oxidase activity
(Shin et al., 2004), the bulk concentration of NO released from these particle-doped
membranes (i.e., <100 μM) was not sufficient to alter the glucose oxidase activity as
determined using an enzymatic spectroscopic assay (Bergmeyer et al., 1974). As such, the
decrease in H2O2 diffusion and glucose sensitivity most likely results from an increase in
membrane thickness. Although RSNO particles were 7 times larger in diameter than N-
diazeniumdiolated particles (Table S1), the sensitivity of the resulting sensors was not
significantly altered as a function of silica particle size.
Although silica is generally regarded as nontoxic (Barbe et al., 2004), the stability of the
NO-releasing dopant within the polyurethane layer was investigated to further assess the
potential in vivo utility of these membranes. Silica particle leaching from the polyurethane
layer into a solution mimicking physiological conditions was examined by soaking NO-
releasing silica particle-doped polyurethane films in PBS (pH 7.4 at 37 °C). For all
membrane compositions, the percent leaching was less than their respective limits of
detection using DLS (<0.6% and <0.3% for N-diazeniumdiolate and RSNO-modified silica
nanoparticle-doped films, respectively) after 7 days, regardless of the NO donor (Table 2).
3.3. Variation of an additional polyurethane layer to alter NO release kinetics
Although NO release from RSNO-functionalized particle-doped polyurethane films was
unaffected by the application of an additional polyurethane layer because temperature and
not water influences RSNO decomposition (data not shown), NO release from N-
diazeniumdiolated particle-doped polyurethane films was tunable via additional polymer
layers to control water uptake and the resulting N-diazeniumdiolate decomposition. As
shown in Table 3, the hydrophobic character of the polyurethane layer cast onto the NO-
releasing layer restricted water access to the NO donor material, thus effectively slowing
NO release. This behavior was expected based on work done previously by Frost et al.
(Frost et al., 2005). When employing Tecoplast TP-470-000 PU (having the lowest water
uptake) as the outer membrane, the maximum NO flux decreased from 77.2 to 25.7 pmol
cm−2 s−1 and NO release duration increased from 2.5 to 189 h relative to Tecophilic
HP-93A-100 PU (having the highest water uptake). The time to reach the maximum NO flux
was also significantly extended from 4 min to 5 h. Although the extent of water uptake
differed among the four types of hydrophobic/hydrophilic polyurethanes, NO-release
character appeared to be bimodal (Figure S3). Both hydrophilic PUs (HP-93A-100 and
AL-25-80A) exhibited fast NO release, while the more hydrophobic PUs (SG-80A and
TP-470-000) had more sustained NO release. Of note, these results may be indicative of a
minimum threshold of water diffusion (water uptake value between 0.2 and 0.6 mg H2O·(mg
PU)−1) necessary to decompose N-diazeniumdiolates. Seemingly above/below this
threshold, there is little effect on NO release kinetics. Both the glucose sensitivity and H2O2
permeability decreased as water uptake of the additional PU layer decreased (Table 3).
However, the dynamic range was extended from 1–6 to 1–25 mM glucose due to reduced O2
saturation. In the case where the most hydrophobic polyurethane (i.e., TP-470-000) was
used to fabricate sensors, little if any glucose response was achieved due to inadequate
analyte permeability (Table 3). Thus, we note an inverse relationship between sustained NO
release and achieving sufficient glucose permeability.
To further alter NO release from the sensor membranes, the polymer concentration and thus
thickness of the additional polyurethane was varied. These studies were carried out using the
Tecoflex SG-80A (TPU) polymer to balance sustained NO release with adequate response to
glucose. As the concentration of the TPU layer was increased from 20 to 60 mg mL−1 (21–
46 μm thick), the NO release duration and time to reach the maximum NO flux both
increased. As expected, the maximum NO flux was suppressed as the diffusion of water
through the membrane decreased (Fig. 1). At 60 mg mL−1 TPU, glucose response was no
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longer achievable (Table 4). The preparation of hydrophobic porous membranes via
electrospun nanofibers doped with NO donors may prove to be a viable alternative for
designing longer NO releasing functional sensors (Coneski et al., 2011).
3.4. Variation of amount of silica particles doped within polyurethane film
Since the RSNO-modified MPTMS/TEOS particle-doped films enable the longest NO
release duration (i.e., 14 d) with minimal silica leaching, this composition was chosen as a
model system for studying the effect of particle concentration on NO release characteristics
and sensor performance. As expected, the total amount and maximum flux of NO release
were enhanced by increasing the concentration of particles doped within the polymer layer
from 0.2 to 2.4 mg cm−2, while the casting volume was held constant (corresponding to 5
μL casting volume of 9–144 mg mL−1 particle solution) (Table 5). The associated NO
release half-life from this film was ∼5 h. Moreover, the film continued to release NO above
the detection limit (i.e., 0.5 pmol cm−2 s−1) after 14 d (Figure S4). The maximum NO flux
and total NO release were ∼2560 pmol cm−2 s−1 and 9.08 μmol cm−2, respectively, for
membranes prepared using the largest particle concentration (2.4 mg cm−2). Although high
levels of NO release may cause apoptosis, NO release from the largest particle concentration
doped-membrane was lower than levels reported to be cytotoxic or apoptosis initiating
(>100 μM) (Cals-Grierson and Ormerod, 2004; Lipton et al., 1993). Additionally, Hetrick et
al. reported that NO-donor modified particles (70% MAP3/TEOS particles) at 8 mg mL−1
releasing 7.6 μmol NO mg−1 inhibited fibroblast proliferation to a lesser extent than clinical
concentrations of currently administered antiseptics (e.g., chlorhexidine) (Hetrick et al.,
2009). Nevertheless, the in vivo utility of these sensor membranes must next be assessed in
an appropriate animal model.
As the concentration of the NO-releasing silica scaffold was increased, we observed
decreased membrane stability. For example, silica particle leaching and loss of membrane
integrity were observed for overloaded polymers, particularly when the particle
concentration was ∼7 times greater than the polymer concentration in which the particle
were dissolved (i.e., 144 mg mL−1 particles in 20 mg mL−1 PU solution). In addition to film
instability, larger dopant concentrations hindered our ability to fabricate homogeneous films
with consistent NO release. For example, larger standard deviations for maximum NO
fluxes were observed for the greatest particle dopant concentrations (Table 5). At greater
local concentrations of NO, the buildup of NO may facilitate accelerated RSNO
decomposition from within the films due to an autocatalytic decomposition mechanism
(Grossi and Montevecchi, 2002). Film thickness increased from 5.67 to 51.63 μm upon
increasing the particle concentration in the films from 0.2 to 2.4 mg cm−2, respectively,
despite keeping the casting volume constant. As a result, biosensor sensitivity was decreased
and response time increased with larger particle concentrations due to decreased analyte
permeability (Table 5).
4. Conclusion
A total NO release of ∼1.35 μmol cm−2 from an implant surface was previously shown to
reduce the FBR (Hetrick et al., 2007). The total and maximum NO flux of the RSNO-
modified MPTMS/TEOS particle-doped (0.6 mg cm−2) films presented here are 6 times
greater with a 4-fold longer duration. Thus, the NO-releasing particle-doped sensor
membranes presented here hold promise for improving the biocompatibility of in vivo
glucose sensors and potential to improve their analytical utility. Moreover, it is clear that our
design allows for tunable NO fluxes and delivery totals by altering: (1) the type of NO-
releasing dopant; (2) the type of polymer utilized; (3) the concentration of additional
polymer layers; and (4) the amount of dopant in the NO-releasing layer. The glucose sensor
performance (i.e., sensitivity, response time, and dynamic range) was affected by these
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modifications and must be evaluated and optimized for each NO-releasing membrane
composition employed in order to fall within the clinically relevant range for in vivo glucose
monitoring. While Hetrick et al. (Hetrick et al., 2007) demonstrated the feasibility of a
particular NO-releasing coating to mitigate the FBR, the materials reported here represent a
broader range of NO donor type, polymer matrix, and NO release characteristics. A
comprehensive in vivo study aimed at characterizing the FBR as a function of NO flux and
duration from equivalent polyurethane membranes is currently underway. Studies evaluating
any benefit of NO release on the analytical performance of implanted needle-type glucose
biosensors are also underway.
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(A) Nitric oxide flux and (B) NO totals from AEAP3/TMOS particle-doped (0.6 mg cm−2)
PU films (●) without and with additional Tecoflex SG-80A (TPU) layer at (○) 20, (■) 40,
and (□) 60 mg mL−1 concentration.
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